FLT3: A narrative review
The adoption of next-generation sequencing (NGS) has unraveled myriad genomic alterations across all myeloid malignancies, changing not only the prognostic paradigm but also the therapeutic paradigm. Many alterations have been incorporated in the classification and categorization of these neoplasia...
Saved in:
| Main Authors: | Nikhil M Kumar, Shrinidhi Nathany, Anusha Swaminathan, Chitresh Yadav, Akriti Kothari, Paritosh Garg, Neha Panda-Rastogi, Vikas Dua, Arun Danewa, Rahul Bhargava |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Cancer Research, Statistics, and Treatment |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/crst.crst_192_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FLT3 and IDH1/2 Inhibitors for Acute Myeloid Leukemia: Focused Clinical Narrative Review of Forthcoming Drugs from an Indian Context
by: Suvir Singh, et al.
Published: (2024-04-01) -
Recurrent Hyperbilirubinemia with Midostaurin during Consolidation in a Patient of AML with FLT3 Mutation and Review of Literature for Alternative Maintenance Strategy
by: Deepak Kumar Shukla, et al.
Published: (2025-08-01) -
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real‐world practice
by: Monica Messina, et al.
Published: (2024-12-01) -
Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia
by: Qi Zhou, et al.
Published: (2025-02-01) -
Gilteritinib maintenance after allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemia with FLT3-internal tandem duplication mutation
by: Chen Liang, et al.
Published: (2025-12-01)